Results 111 to 120 of about 38,812 (326)
Central mechanisms of emesis: A role for GDF15
Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.Abstract Background Nausea and emesis are ubiquitously reported medical conditions and often present as treatment side effects along with polymorbidities contributing to detrimental life‐threatening outcomes, such as poor nutrition, lower quality of life, and unfavorable patient prognosis.
Tito Borner +2 more
wiley +1 more source
Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.Abstract Background Cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS) are both characterized by episodic, acute transitions from asymptomatic states to highly symptomatic states of nausea, repetitive vomiting, and often severe abdominal pain.
David J. Levinthal +2 more
wiley +1 more source
New aspects of supportive care: The MASCC vision [PDF]
, 2004 The Multinational Association of Supportive Care in Cancer (MASCC) was founded in 1991, and joined forces with the International Society of Oral Oncology (ISOO) in 1998.
Herrstedt Jorn
core +1 more source
Anesthesia and Analgesia, 1999 UNLABELLED Nausea and vomiting are frequent adverse effects of patient-controlled analgesia (PCA) with opioids. To identify the optimal prophylactic antiemetic intervention in this setting, we performed a systematic search for randomized trials (MEDLINE,
M. Tramèr, Bernhard Walder
semanticscholar +1 more source
Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.Roadmap to Patient‐Focused Outcome Measurement in Clinical Trials. Source: US FDA, “Patient‐Focused Drug Development: Selecting, Developing, or Modifying Fit‐for‐Purpose Clinical Outcome Assessments”, Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholder.
Yaozhu J. Chen +2 more
wiley +1 more source
Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting [PDF]
, 2018 Background: We assessed adherence to the European Society of Medical Oncology (ESMO)/Multinational Association of Supportive Care in Cancer recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (CINV) at our institution.
Aebi, Stefan +4 more
core
Endocannabinoid signaling in stress, nausea, and vomiting
Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.Abstract Background Classical antiemetics that target the serotonin system may not be effective in treating certain nausea and vomiting conditions like cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS). As a result, there is a need for better therapies to manage the symptoms of these disorders, including nausea, vomiting, and ...
Marieka V. DeVuono +2 more
wiley +1 more source
Propofol: A Medication That Changed Pediatric Anesthesia Practice
Pediatric Anesthesia, EarlyView.ABSTRACT The introduction of propofol changed our understanding of pediatric anesthesia pharmacology, research approaches for intravenous drug study, and led to infusion pump development for the maintenance phase of anesthesia. The story of propofol development provides a blueprint for other intravenous drug development.
Brian J. Anderson, L. Ignacio Cortinez
wiley +1 more source
Headache and pregnancy. a systematic review [PDF]
, 2017 This systematic review summarizes the existing data on headache and pregnancy with a scope on clinical headache phenotypes, treatment of headaches in pregnancy and effects of headache medications on the child during pregnancy and breastfeeding, headache ...
A. Negro +9 more
core +1 more source